In clinical trials the Sanofi/GSK vaccine had results comparable to the COVID-19 mRNA vaccines and has been recommended by the JCVI for people over 75.
Mewn treialon clinigol, roedd canlyniadau brechlyn Sanofi/GSK yn gymaradwy â chanlyniadau’r brechlynnau mRNA COVID-19.